Product Program year 2025 Source: CMS Open Payments

Tissueblue

Drug Ophthalmology

NDC 68803-722-05

Open in the dashboard

General payments

$297,994

989 payments

Research payments

$0

0 payments

Through program year 2025, $297,994 in general payments and $0 in research payments were reported against Tissueblue (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $13,912 146
2024 General $97,155 400
2023 General $179,427 440
2020 General $7,500 3

Breakdown

Who paid General payments · program years 2020–2025
  1. Dutch Ophthalmic, USA $272,237 937 payments
  2. Dutch Ophthalmic Research Center (International) B.V. $25,757 52 payments
Top recipients General payments · program year 2025
  1. Austin Strohbehn Retina Specialist · West Des Moines, IA $2,250 16% · 1 payment
  2. Carl Awh Retina Specialist · Nashville, TN $1,083 8% · 5 payments
  3. Hong-Uyen Hua Retina Specialist · Miami, FL $314 2% · 3 payments
  4. Kapil Mishra Retina Specialist · Irvine, CA $292 2% · 2 payments
  5. Murtaza Adam Retina Specialist · Parker, CO $291 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Retina Specialist Ophthalmology $7,339 53% · 37 practitioners
  2. Ophthalmology $5,134 37% · 65 practitioners
  3. Physician Assistant $307 2% · 3 practitioners
  4. Optometrist $246 2% · 3 practitioners
  5. Glaucoma Specialist Ophthalmology $218 2% · 2 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Iowa $2,250 16% · 1 recipient
  2. Ohio $2,185 16% · 28 recipients
  3. Florida $1,713 12% · 17 recipients
  4. California $1,495 11% · 12 recipients
  5. Tennessee $1,145 8% · 2 recipients

The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

989 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record